Home - Boston Life Sciences Times

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

April 22, 2026

THIS WEEK'S STORIES

Prilenia Therapeutics Names Elisabeth Leiderman as Chief Financial Officer

April 28, 2026

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

April 29, 2026

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

April 28, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Most Popular

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Strand Therapeutics Names Kunal Bhatia Chief Financial Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

Recent Comments

EDITOR PICKS

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

THIS WEEK'S STORIES

Prilenia Therapeutics Names Elisabeth Leiderman as Chief Financial Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

POPULAR CATEGORY

ABOUT US

FOLLOW US

LATEST ARTICLES

Most Popular

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US